Resultados de búsqueda - Bastón-Rey, I
-
1
Dysplasia screening in inflammatory bowel disease patients: to whom, when and how
Artículo | por Ballester MP; de Célix CR; Madero L; Calafat M; Baston-Rey I; Brunet-Mas E | Publicado 2025 |Otros Autores: “…Baston-Rey I…”
-
2
Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of i...
Artículo | por Ginard, D; Fontanillas, N; Bastón-Rey, I; Pejenaute, ME; Piqueras, M; Alcalde, S; Nos, P; Ricote, M; Expósito, L; Mañosa, M; Barreiro-de Acosta, M; Rodríguez-Moranta, F; Zabana, Y; Polo, J; Gutiérrez, A | Publicado 2025 |Otros Autores: “…Bastón-Rey, I…”
-
3
Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of i...
Artículo | por Ginard, D; Fontanillas, N; Bastón-Rey, I; Pejenaute, ME; Piqueras, M; Alcalde, S; Nos, P; Ricote, M; Expósito, L; Mañosa, M; Barreiro-de Acosta, M; Rodríguez-Moranta, F; Zabana, Y; Polo, J; Gutiérrez, A | Publicado 2025 |Otros Autores: “…Bastón-Rey, I…”
-
4
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Artículo | por Mesonero, F; Zabana, Y; Fernández-Clotet, A; Leo-Carnerero, E; Caballol, B; Núñez-Ortiz, A; García, MJ; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, LJ; Fajardo, I; Torrealba, L; Nájera, R; Saíz-Chumillas, RM; González, I; Vicuña, M; García-Morales, N; Gutiérrez, A; López-García, A; Benítez, JM; de Célix, CR; Tejido, C; Brunet, E; Hernández-Camba, A; Suárez, C; Rodríguez-Lago, I; Piqueras, M; Castaño, A; Ramos, L; Sobrino, A; Rodríguez-Grau, MC; Elosua, A; Montoro, M; Baltar, R; Huguet, JM; Hermida, B; Caballero-Mateos, A; Sánchez-Guillén, L; Bouhmidi, A; Pajares, R; Baston-Rey, I; López-Sanromán, A; Albillos, A; Barreiro-de Acosta, M | Publicado 2024 |Otros Autores: “…Baston-Rey, I…”
-
5
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Artículo | por Chaparro, M; Baston-Rey, I; Salgado, EF; Garcia, JG; Ramos, L; Palomares, MTDL; Arguelles-Arias, F; Flores, EI; Cabello, M; Iturria, SR; Ortiz, AN; Charro, M; Ginard, D; Sadornil, CD; Ochoa, OM; Busquets, D; Iyo, E; Casbas, AG; de la Piscina, PR; Bosca-Watts, MM; Arroyo, M; Garcia, MJ; Hinojosa, E; Gordillo, J; Montiel, PM; Jimenez, BV; Ivorra, CQ; Moron, JMV; Huguet, JM; Gonzalez-Lama, Y; Santos, AIM; Amo, VM; Arranz, MDM; Bermejo, F; Cadilla, JM; de Celix, CR; Salazar, PF; San Roman, AL; Jimenez, N; Garcia-Lopez, S; Figuerola, A; Jimenez, I; Cerezo, FJM; Taxonera, C; Varela, P; de Francisco, R; Monfort, D; Arriero, GM; Hernandez-Camba, A; Alonso, FJG; Van Domselaar, M; Pajares-Villarroya, R; Nunez, A; Moranta, FR; Marin-Jimenez, I; Alonso, VR; Rodriguez, MDM; Camo-Monterde, P; Tercero, IG; Navarro-Llavat, M; Garcia, LA; Cruz, DH; Kloss, S; Passey, A; Novella, C; Vispo, E; Barreiro-de Acosta, M; Gisbert, JP | Publicado 2022 |Otros Autores: “…Baston-Rey, I…”
-
6
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Artículo | por Chaparro, M; Baston-Rey, I; Salgado, EF; Garcia, JG; Ramos, L; Palomares, MTDL; Arguelles-Arias, F; Flores, EI; Cabello, M; Iturria, SR; Ortiz, AN; Charro, M; Ginard, D; Sadornil, CD; Ochoa, OM; Busquets, D; Iyo, E; Casbas, AG; de la Piscina, PR; Bosca-Watts, MM; Arroyo, M; Garcia, MJ; Hinojosa, E; Gordillo, J; Montiel, PM; Jimenez, BV; Ivorra, CQ; Moron, JMV; Huguet, JM; Gonzalez-Lama, Y; Santos, AIM; Amo, VM; Arranz, MDM; Bermejo, F; Cadilla, JM; de Celix, CR; Salazar, PF; San Roman, AL; Jimenez, N; Garcia-Lopez, S; Figuerola, A; Jimenez, I; Cerezo, FJM; Taxonera, C; Varela, P; de Francisco, R; Monfort, D; Arriero, GM; Hernandez-Camba, A; Alonso, FJG; Van Domselaar, M; Pajares-Villarroya, R; Nunez, A; Moranta, FR; Marin-Jimenez, I; Alonso, VR; Rodriguez, MDM; Camo-Monterde, P; Tercero, IG; Navarro-Llavat, M; Garcia, LA; Cruz, DH; Kloss, S; Passey, A; Novella, C; Vispo, E; Barreiro-de Acosta, M; Gisbert, JP | Publicado 2022 |Otros Autores: “…Baston-Rey, I…”
-
7
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Artículo | por Mesonero, F; Zabana, Y; Fernández-Clotet, A; Leo-Carnerero, E; Caballol, B; Núñez-Ortiz, A; García, MJ; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, LJ; Fajardo, I; Torrealba, L; Nájera, R; Saíz-Chumillas, RM; González, I; Vicuña, M; García-Morales, N; Gutiérrez, A; López-García, A; Benítez, JM; de Célix, CR; Tejido, C; Brunet, E; Hernández-Camba, A; Suárez, C; Rodríguez-Lago, I; Piqueras, M; Castaño, A; Ramos, L; Sobrino, A; Rodríguez-Grau, MC; Elosua, A; Montoro, M; Baltar, R; Huguet, JM; Hermida, B; Caballero-Mateos, A; Sánchez-Guillén, L; Bouhmidi, A; Pajares, R; Baston-Rey, I; López-Sanromán, A; Albillos, A; Barreiro-de Acosta, M | Publicado 2024 |Otros Autores: “…Baston-Rey, I…”
-
8
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers.
Artículo | por Baldán-Martín M; Iloro I; Azkargorta M; Soleto I; Orejudo M; Ramirez C; Mercado J; Suárez-Trujillo F; Sánchez-Sánchez C; Garre A; Riestra S; Rivero M; Gutiérrez A; Rodríguez-Lago I; Fernández-Salazar L; Ceballos D; Benítez JM; Aguas M; Bastón-Rey I; Bermejo F; Casanova MJ; Lorente-Poyatos RH; Ber Y; Ginard D; Esteve M; De Francisco R; García MJ; Francés R; Cabriada JL; Soto P; Nos P; Acosta MB; Guerra I; Cruz DH; Domínguez Cajal M; Royo V; Aceituno M; Martín-Cófreces NB; Elortza F; Gisbert JP; Chaparro M | Publicado 2025 |Otros Autores: “…Bastón-Rey I…”
-
9
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Artículo | por Mesonero, F; Zabana, Y; Fernández-Clotet, A; Leo-Carnerero, E; Caballol, B; Núñez-Ortiz, A; García, MJ; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, LJ; Fajardo, I; Torrealba, L; Nájera, R; Saíz-Chumillas, RM; González, I; Vicuña, M; García-Morales, N; Gutiérrez, A; López-García, A; Benítez, JM; de Célix, CR; Tejido, C; Brunet, E; Hernández-Camba, A; Suárez, C; Rodríguez-Lago, I; Piqueras, M; Castaño, A; Ramos, L; Sobrino, A; Rodríguez-Grau, MC; Elosua, A; Montoro, M; Baltar, R; Huguet, JM; Hermida, B; Caballero-Mateos, A; Sánchez-Guillén, L; Bouhmidi, A; Pajares, R; Baston-Rey, I; López-Sanromán, A; Albillos, A; Barreiro-de Acosta, M | Publicado 2024 |Otros Autores: “…Baston-Rey, I…”
-
10
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Artículo | por Mesonero, F; Zabana, Y; Fernández-Clotet, A; Leo-Carnerero, E; Caballol, B; Núñez-Ortiz, A; García, MJ; Bertoletti, F; Mínguez, A; Suris, G; Casis, B; Ferreiro-Iglesias, R; Calafat, M; Jiménez, I; Miranda-Bautista, J; Lamuela, LJ; Fajardo, I; Torrealba, L; Nájera, R; Saíz-Chumillas, RM; González, I; Vicuña, M; García-Morales, N; Gutiérrez, A; López-García, A; Benítez, JM; de Célix, CR; Tejido, C; Brunet, E; Hernández-Camba, A; Suárez, C; Rodríguez-Lago, I; Piqueras, M; Castaño, A; Ramos, L; Sobrino, A; Rodríguez-Grau, MC; Elosua, A; Montoro, M; Baltar, R; Huguet, JM; Hermida, B; Caballero-Mateos, A; Sánchez-Guillén, L; Bouhmidi, A; Pajares, R; Baston-Rey, I; López-Sanromán, A; Albillos, A; Barreiro-de Acosta, M | Publicado 2024 |Otros Autores: “…Baston-Rey, I…”
Herramientas de búsqueda:
Materias Relacionadas
ustekinumab
pouchitis
Crohn's disease
inflammatory bowel disease
ulcerative colitis
azathioprine
immunosuppressants
predictive factors
thiopurines
Crohn's Disease
Crohn’s disease
anti-TNF
effectiveness
postoperative complications
preoperative therapy
real-world evidence
safety
surgery
vedolizumab
Crohn's disease of the pouch
Diagnosis
GETECCU
Gastroenterology
Inflammatory bowel disease
Management
Primary care
SEMERGEN
biological therapy
Crohn’s Disease
biomarkers